Edwards Lifesciences reported $759.5M in Stock for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Abiomed ABMD:US $ 83.66M 2.6M
Atricure ATRC:US $ 37.61M 1.46M
Baxter International BAX:US $ 2065M 48M
Becton, Dickinson and BDX:US $ 2947M 52M
Cardiovascular Systems CSII:US $ 32.31M 1.05M
Cooper Companies COO:US $ 587.9M 5.9M
Dexcom DXCM:US $ 319.3M 29.6M
Edwards Lifesciences EW:US $ 759.5M 8.4M
Globus Medical GMED:US $ 231.21M 799K
Hill Rom HRC:US $ 329.1M 1.6M
Hologic HOLX:US $ 502.9M 46.7M
Icu Medical ICUI:US $ 299.61M 0.48M
Inogen INGN:US $ 27.22M 0.83M
Insulet PODD:US $ 197.8M 27.7M
Integra Lifesciences IART:US $ 323.62M 4.43M
Intuitive Surgical ISRG:US $ 569.7M 7.1M
Masimo MASI:US $ 206.61M 9.54M
Medtronic MDT:US $ 4288M 25M
Nuvasive NUVA:US $ 319.73M 3.98M
Stryker SYK:US $ 3431M 42M
Teleflex TFX:US $ 490.32M 21.97M
Zimmer Biomet Holdings Inc ZBH:US $ 2.53B 21.3M